Literature DB >> 2532552

Competition between solution and cell surface receptors for ligand. Dissociation of hapten bound to surface antibody in the presence of solution antibody.

B Goldstein1, R G Posner, D C Torney, J Erickson, D Holowka, B Baird.   

Abstract

We present a joint theoretical and experimental study on the effects of competition for ligand between receptors in solution and receptors on cell surfaces. We focus on the following experiment. After ligand and cell surface receptors equilibrate, solution receptors are introduced, and the dissociation of surface bound ligand is monitored. We derive theoretical expressions for the dissociation rate and compare with experiment. In a standard dissociation experiment (no solution receptors present) dissociation may be slowed by rebinding, i.e., at high receptor densities a ligand that dissociates from one receptor may rebind to other receptors before separating from the cell. Our theory predicts that rebinding will be prevented when S much greater than N2Kon/(16 pi 2D a4), where S is the free receptor site concentration in solution, N the number of free surface receptor sites per cell, Kon the forward rate constant for ligand-receptor binding in solution, D the diffusion coefficient of the ligand, and a the cell radius. The predicted concentration of solution receptors needed to prevent rebinding is proportional to the square of the cell surface receptor density. The experimental system used in these studies consists of a monovalent ligand, 2,4-dinitrophenyl (DNP)-aminocaproyl-L-tyrosine (DCT), that reversibly binds to a monoclonal anti-DNP immunoglobulin E (IgE). This IgE is both a solution receptor and, when anchored to its high affinity Fc epsilon receptor on rat basophilic leukemia (RBL) cells, a surface receptor. For RBL cells with 6 x 10(5) binding sites per cell, our theory predicts that to prevent DCT rebinding to cell surface IgE during dissociation requires S much greater than 2,400 nM. We show that for S = 200-1,700 nM, the dissociation rate of DCT from surface IgE is substantially slower than from solution IgE where no rebinding occurs. Other predictions are also tested and shown to be consistent with experiment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532552      PMCID: PMC1280594          DOI: 10.1016/S0006-3495(89)82741-9

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  23 in total

1.  HIV infection is blocked in vitro by recombinant soluble CD4.

Authors:  R A Fisher; J M Bertonis; W Meier; V A Johnson; D S Costopoulos; T Liu; R Tizard; B D Walker; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

2.  The effect of receptor density on the forward rate constant for binding of ligands to cell surface receptors.

Authors:  J Erickson; B Goldstein; D Holowka; B Baird
Journal:  Biophys J       Date:  1987-10       Impact factor: 4.033

3.  Association of a protein with membrane vesicles at the collisional limit: studies with blood coagulation factor Va light chain also suggest major differences between small and large unilamellar vesicles.

Authors:  A J Abbott; G L Nelsestuen
Journal:  Biochemistry       Date:  1987-12-01       Impact factor: 3.162

4.  The effect of cell size and receptor density on ligand--receptor reaction rate constants.

Authors:  C DeLisi
Journal:  Mol Immunol       Date:  1981-06       Impact factor: 4.407

5.  The released interleukin 2 receptor binds interleukin 2 efficiently.

Authors:  L A Rubin; G Jay; D L Nelson
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

6.  Analysis of the rate-limiting step in a ligand-cell receptor interaction: the immunoglobulin E system.

Authors:  S A Wank; C DeLisi; H Metzger
Journal:  Biochemistry       Date:  1983-02-15       Impact factor: 3.162

7.  Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.

Authors:  D H Smith; R A Byrn; S A Marsters; T Gregory; J E Groopman; D J Capon
Journal:  Science       Date:  1987-12-18       Impact factor: 47.728

8.  Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy.

Authors:  D B Golden; D A Meyers; A Kagey-Sobotka; M D Valentine; L M Lichtenstein
Journal:  J Allergy Clin Immunol       Date:  1982-06       Impact factor: 10.793

9.  Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.

Authors:  H R Gelderblom; E H Hausmann; M Ozel; G Pauli; M A Koch
Journal:  Virology       Date:  1987-01       Impact factor: 3.616

10.  Cross-linking of IgE-receptor complexes at the cell surface: a fluorescence method for studying the binding of monovalent and bivalent haptens to IgE.

Authors:  J Erickson; P Kane; B Goldstein; D Holowka; B Baird
Journal:  Mol Immunol       Date:  1986-07       Impact factor: 4.407

View more
  25 in total

1.  Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis.

Authors:  W S Hlavacek; C Wofsy; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Steric effects on multivalent ligand-receptor binding: exclusion of ligand sites by bound cell surface receptors.

Authors:  W S Hlavacek; R G Posner; A S Perelson
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

3.  Interrupting autocrine ligand-receptor binding: comparison between receptor blockers and ligand decoys.

Authors:  K E Forsten; D A Lauffenburger
Journal:  Biophys J       Date:  1992-09       Impact factor: 4.033

4.  Dimerization kinetics of the IgE-class antibodies by divalent haptens. I. The Fab-hapten interactions.

Authors:  R Schweitzer-Stenner; A Licht; I Pecht
Journal:  Biophys J       Date:  1992-08       Impact factor: 4.033

5.  Autocrine ligand binding to cell receptors. Mathematical analysis of competition by solution "decoys".

Authors:  K E Forsten; D A Lauffenburger
Journal:  Biophys J       Date:  1992-02       Impact factor: 4.033

Review 6.  Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

7.  Effects of receptor clustering on ligand dissociation kinetics: theory and simulations.

Authors:  Manoj Gopalakrishnan; Kimberly Forsten-Williams; Matthew A Nugent; Uwe C Täuber
Journal:  Biophys J       Date:  2005-09-08       Impact factor: 4.033

8.  Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time.

Authors:  Georges Vauquelin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-28       Impact factor: 3.000

9.  Ligand rebinding: self-consistent mean-field theory and numerical simulations applied to surface plasmon resonance studies.

Authors:  Manoj Gopalakrishnan; Kimberly Forsten-Williams; Theresa R Cassino; Luz Padro; Thomas E Ryan; Uwe C Täuber
Journal:  Eur Biophys J       Date:  2005-04-06       Impact factor: 1.733

10.  Are assumptions about the model type necessary in reaction-diffusion modeling? A FRAP application.

Authors:  Juliane Mai; Saskia Trump; Rizwan Ali; R Louis Schiltz; Gordon Hager; Thomas Hanke; Irina Lehmann; Sabine Attinger
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.